Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2). [electronic resource] by
- Kavanaugh, A
- Kremer, J
- Ponce, L
- Cseuz, R
- Reshetko, O V
- Stanislavchuk, M
- Greenwald, M
- Van der Aa, A
- Vanhoutte, F
- Tasset, C
- Harrison, P
Producer: 20170814
In:
Annals of the rheumatic diseases vol. 76
Availability: No items available.
|
|
7.
|
Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1). [electronic resource] by
- Westhovens, R
- Taylor, P C
- Alten, R
- Pavlova, D
- Enríquez-Sosa, F
- Mazur, M
- Greenwald, M
- Van der Aa, A
- Vanhoutte, F
- Tasset, C
- Harrison, P
Producer: 20170814
In:
Annals of the rheumatic diseases vol. 76
Availability: No items available.
|
|
8.
|
Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases. [electronic resource] by
- Vermeulen, K
- Strnad, M
- Krystof, V
- Havlícek, L
- Van der Aa, A
- Lenjou, M
- Nijs, G
- Rodrigus, I
- Stockman, B
- van Onckelen, H
- Van Bockstaele, D R
- Berneman, Z N
Producer: 20020403
In:
Leukemia vol. 16
Availability: No items available.
|